Fundraising Fox

Tetragenetics

Cambridge, US · New York corporation · 3 known investors

tetragenetics.com ↗

Biotechnology company with proprietary technology for ion channel antigens in antibody discovery programs.

Biotech

Founders & leadership

KO
Kevin O'BrienExecutive Officer
RG
Robert GailusDirector
RD
R. Douglas KahnExecutive Officer, Director
MG
Martin GorovskyDirector
TC
Theodore ClarkExecutive Officer, Director
BM
Ben MachielseDirector
CT
Christopher TaronDirector

Investors · 3

Bantam GroupWestwood
Boston Harbor AngelsBoston · $250K – $1.5M
NXT VenturesMarblehead · $250K – $1M

Reported raises · per SEC filings

Form D private placements
▶$1MraisedSep 2020 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher TaronDirector
  • Ellen BaronDirector
  • Kevin O'BrienExecutive Officer
  • Peter KienerDirector
  • Alison Taunton-RigbyDirector
  • Robert GailusDirector
  • Theodore ClarkExecutive Officer, Director
  • R Douglas KahnExecutive Officer, Director
  • Daniel GrauDirector
Offering amount
$2M
Amount sold
$1M
Minimum investment
$10K
First sale
Sep 2020
Incorporated
Corporation, New York
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$809.8KraisedJul 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Theodore ClarkExecutive Officer, Director
  • Robert GailusDirector
  • Christopher TaronDirector
  • Kevin O'BrienExecutive Officer
  • Peter KienerDirector
  • R Douglas KahnExecutive Officer, Director
Offering amount
$2M
Amount sold
$809.8K
Minimum investment
$25K
First sale
Jun 2018
Incorporated
Corporation, New York
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMar 2017 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin O'BrienExecutive Officer
  • Christopher TaronDirector
  • Martin GorovskyDirector
  • Peter KienerDirector
  • Theodore ClarkExecutive Officer, Director
  • Robert GailusDirector
  • R Douglas KahnExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.1M
Minimum investment
$10K
First sale
Feb 2017
Incorporated
Corporation, New York
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$336KraisedNov 2015 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • R. Douglas KahnExecutive Officer, Director
  • Robert GailusDirector
  • Martin GorovskyDirector
  • Kevin O'BrienExecutive Officer
  • Theodore ClarkExecutive Officer, Director
  • Ben MachielseDirector
  • Christopher TaronDirector
Offering amount
$1.5M
Amount sold
$336K
Minimum investment
$10K
First sale
Nov 2015
Incorporated
Corporation, New York
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$338.2KraisedMar 2015 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin O'BrienExecutive Officer
  • Robert GailusDirector
  • R. Douglas KahnExecutive Officer, Director
  • Martin GorovskyDirector
  • Theodore ClarkExecutive Officer, Director
  • Ben MachielseDirector
  • Christopher TaronDirector
Offering amount
$1.5M
Amount sold
$338.2K
Minimum investment
$10K
First sale
Mar 2015
Incorporated
Corporation, New York
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.